Akorn Inc (AKRX) 25.08 $AKRX
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2015 Update
John Vincent - at Seeking Alpha - Sun Feb 21, 6:17AM CST
SIRO: 109.97 (-0.13), MON: 85.89 (+0.95), EVHC: 23.25 (-0.30), PRU: 71.47 (-0.40), NKE: 61.26 (-0.21), KSU: 86.65 (+0.23), AMP: 90.46 (+0.92), LM: 32.42 (+0.57), RRC: 32.32 (+1.59), AET: 108.06 (-1.58), GOOG: 710.89 (-1.53), GPOR: 25.60 (+0.33), HOT: 70.55 (+0.48), HLT: 21.89 (+0.30), LYB: 82.00 (+2.10), COG: 21.47 (-0.70), WCG: 93.24 (-0.36), MA: 90.05 (+0.31), MNK: 62.15 (-1.44), WUBA: 55.70 (+1.45), WLL: 7.09 (+0.78), VRTX: 88.36 (-1.09), MCK: 162.77 (+0.07), ETN: 57.95 (+0.12), SEE: 45.68 (-0.84), AKRX: 25.08 (-0.80), PFE: 29.71 (-0.18), HAL: 34.88 (+0.71), LNG: 38.04 (+0.99), ETE: 8.33 (+0.43), TXT: 33.00 (-0.64), ALL: 65.38 (+0.07), PCLN: 1,297.71 (-5.33), QUNR: 36.95 (+0.73), WBA: 79.45 (-0.47), PXD: 128.80 (+0.53), MCD: 117.18 (+0.49), TEVA: 55.62 (+0.02), DOV: 63.20 (+0.75), AIG: 52.30 (+0.03), XRAY: 60.16 (-0.46), FDC: 13.59 (+0.80), CCI: 87.25 (-0.64), BIIB: 263.94 (-4.70), VRX: 61.31 (-3.58), CPN: 14.14 (+0.26), C: 42.83 (unch), ILMN: 156.14 (-1.31), CB: 117.18 (-0.66), MMC: 58.01 (+0.26), HUM: 183.25 (+0.03), AGN: 288.67 (-0.95), ANTM: 132.35 (-0.62), ECA: 5.47 (+0.54), PRQR: 4.54 (+0.14), EBAY: 24.41 (+0.47), SHPG: 160.39 (+0.20), CMG: 529.00 (+4.71), GOOGL: 730.22 (-1.37), CTRP: 40.02 (+0.78), SWN: 7.83 (+0.49), BK: 38.09 (+0.40), APD: 134.79 (-0.09), BHI: 46.20 (-0.35), APC: 45.26 (+2.28), AMZN: 575.14 (-2.35), ENDP: 42.44 (-0.73), MAR: 68.98 (+0.30), NFLX: 101.58 (+3.65), DVA: 70.51 (+0.43), KITE: 54.44 (+2.70), MHK: 186.82 (-0.07), TDG: 222.68 (+3.05), LH: 112.17 (+0.25), CP: 125.26 (+3.28), AFL: 61.03 (+0.05), AVGO: 146.06 (+8.73), BABA: 72.22 (+1.20)
Tracking John Paulson's Paulson & Company Portfolio - Q4 2015 Update
John Vincent - at Seeking Alpha - Sat Feb 20, 1:39PM CST
SGYP: 3.47 (-0.01), PRGO: 126.61 (+0.19), CAM: 67.79 (-0.03), CHTR: 184.78 (+1.11), INTC: 30.63 (+0.05), PCP: 234.95 (+0.10), SLB: 74.83 (-0.02), CYBX: 69.95 (+0.86), HOT: 70.55 (+0.48), STAY: 14.82 (-0.27), CSC: 30.51 (-0.26), TMUS: 38.48 (-0.49), MNK: 62.15 (-1.44), WLL: 7.09 (+0.78), AKRX: 25.08 (-0.80), NCQ: 0.46 (+0.05), AU: 12.92 (-0.36), MYL: 44.78 (-0.95), MGM: 19.81 (-0.52), WWAV: 41.15 (+0.60), NG: 5.02 (-0.01), LIVN: 57.94 (+0.19), TEVA: 55.62 (+0.02), AIG: 52.30 (+0.03), BRK.B: 137.97 (+1.13), BRK.A: 207,945.00 (+1,945.00), OAS: 6.91 (+0.22), VRX: 61.31 (-3.58), VNDA: 7.92 (-0.21), ALTR: 53.96 (+0.03), CZR: 8.80 (-0.15), CVC: 33.28 (+0.03), CIE: 3.41 (+0.21), AGN: 288.67 (-0.95), CACQ: 5.75 (-0.15), SHPG: 160.39 (+0.20), TWC: 195.33 (+0.90), BXLT: 39.47 (+0.17), ENDP: 42.44 (-0.73), OUT: 21.56 (+0.06), BAC: 13.54 (+0.04), MAR: 68.98 (+0.30), GRFS: 15.22 (-0.27), HCA: 73.00 (+0.07), POST: 71.75 (-0.45), RDN: 11.94 (+0.16), LRCX: 74.33 (-0.54), BAX: 39.46 (+0.13), GLD: 120.54 (-0.19), RLGY: 34.27 (+0.38), CIT: 33.17 (+1.11), HMHC: 19.96 (+0.19), MTG: 7.55 (-0.02), CSRA: 25.82 (-0.30)
Akorn Has Returned 20.2% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Feb 05, 10:52AM CST
SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on January 12th, 2016 at $31.33. In approximately 3 weeks, Akorn has returned 20.20% as of today's recent price of $25.00.
AKRX: 25.08 (-0.80)
Shares of AKRX Down 14.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 28, 5:41PM CST
SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on January 12th, 2016 at $31.33. In approximately 2 weeks, Akorn has returned 14.55% as of today's recent price of $26.77.
AKRX: 25.08 (-0.80)
Akorn Announces Conclusion of Audit Committee Independent Investigation
GlobeNewswire - Wed Jan 27, 3:34PM CST
Akorn, Inc. (Nasdaq:AKRX) today announced that the Audit Committee of Akorn's Board of Directors concluded its independent investigation into Akorn's accounting and other matters.
AKRX: 25.08 (-0.80)
Akorn Appoints Greg Lawless as Chief Human Resources Officer
GlobeNewswire - Thu Jan 21, 6:06AM CST
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P. Lawless joined Akorn as Chief Human Resources Officer on January 18, 2016.
AKRX: 25.08 (-0.80)
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
GlobeNewswire - Tue Jan 19, 6:00AM CST
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched Buprenorphine and Naloxone Sublingual Tablets CIII in 2mg/0.5mg and 8mg/2mg strengths. This launch follows an October 15, 2015 Food and Drug Administration (FDA) approval for the product. Additionally, Akorn recently launched Tobramycin Injection, USP 40 mg/mL in 2 mL and 30 mL multi-dose vials. This launch follows a September 2014 approval for the product.
AKRX: 25.08 (-0.80)
Why Akorn, Inc. Stock Dropped 10% Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Jan 15, 2:30PM CST
Image source: Akorn. W hat: Following a business update related to its ongoing investigation of material weakness in its financial accounting, shares of Akorn fell 10% earlier today. So what: After revealing material weaknesses early...
AKRX: 25.08 (-0.80)
Akorn Provides Material Updates
GlobeNewswire - Thu Jan 14, 4:25PM CST
- BDO USA, LLP Engaged as Independent Registered Public Accounting Firm -
AKRX: 25.08 (-0.80)
Look for Shares of Akorn to Potentially Rebound after Yesterday's 11.64% Sell Off
Comtex SmarTrend(R) - Tue Jan 12, 4:21PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $28.41 to a high of $34.25. Yesterday, the shares fell 11.6%, which took the trading range below the 3-day low of $32.57 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 25.08 (-0.80)
Shares of AKRX Up 19.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Jan 11, 6:37PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 19.30% as of today's recent price of $33.75.
AKRX: 25.08 (-0.80)
Top-Notch Funds Buying Constellation, Northrop Grumman
at Investor's Business Daily - Fri Jan 08, 4:56PM CST
The Santa Claus rally fizzled out in the later part of December amid the oil rout and the Fed's long-awaited rate bump. The S&P 500 rose 6.8% for the fourth quarter, but edged down 1.6% in December. The Nasdaq gained 8.4% in the last quarter of the...
GE: 30.46 (+0.24), NOC: 191.07 (-1.05), AKRX: 25.08 (-0.80), PSA: 249.95 (-3.26), STZ: 143.90 (-0.55), EXR: 83.98 (-0.85), ELS: 70.85 (-1.22), ICLR: 71.95 (-0.42), NVDA: 32.55 (-0.10), LUV: 41.50 (-0.53), AGN: 288.67 (-0.95), CNC: 58.75 (-1.57), ISRG: 570.65 (-3.39), CBPO: 110.00 (-0.70), AYI: 220.30 (-1.83), ULTA: 168.97 (-0.41)
Shares of AKRX Up 34.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Jan 04, 4:48PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 34.68% as of today's recent price of $38.10.
AKRX: 25.08 (-0.80)
Akorn Has Returned 31.6% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Mon Dec 28, 9:20AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 31.64% as of today's recent price of $37.24.
AKRX: 25.08 (-0.80)
Akorn Set to Possibly Pullback After Yesterday's Rally of 1.55%
Comtex SmarTrend(R) - Tue Dec 22, 4:52PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.40 to a high of $37.14. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $36.83 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 25.08 (-0.80)
27.4% Return Seen to Date on SmarTrend Akorn Call (AKRX)
Comtex SmarTrend(R) - Fri Dec 18, 7:58PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 1 month, Akorn has returned 27.36% as of today's recent price of $36.03.
AKRX: 25.08 (-0.80)
Akorn Shares Up 22.2% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Dec 11, 6:16PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 1 month, Akorn has returned 22.20% as of today's recent price of $34.57.
AKRX: 25.08 (-0.80)
Akorn Up 23.5% Since SmarTrend Uptrend Call (AKRX)
Comtex SmarTrend(R) - Fri Dec 04, 1:42PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 4 weeks, Akorn has returned 23.52% as of today's recent price of $34.95.
AKRX: 25.08 (-0.80)
Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Wed Dec 02, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Neutral to Buy at Nomura today. The stock closed yesterday at $34.55 on volume of 1.2 million shares, below average daily volume of 1.6 million. In the past 52 weeks, Akorn share prices have been bracketed by a low of $19.08 and a high of $57.10 and closed yesterday at $34.55, 81% above that low price. The 200-day and 50-day moving averages have moved 0.5% lower and 1.02% lower over the past week, respectively.
AKRX: 25.08 (-0.80)
Uptrend Call Working As Akorn Stock Rises 18.6% (AKRX)
Comtex SmarTrend(R) - Fri Nov 27, 11:14AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 3 weeks, Akorn has returned 18.59% as of today's recent price of $33.55.
AKRX: 25.08 (-0.80)
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2015 Update
John Vincent - at Seeking Alpha - Sun Feb 21, 6:17AM CST
SIRO: 109.97 (-0.13), MON: 85.89 (+0.95), EVHC: 23.25 (-0.30), PRU: 71.47 (-0.40), NKE: 61.26 (-0.21), KSU: 86.65 (+0.23), AMP: 90.46 (+0.92), LM: 32.42 (+0.57), RRC: 32.32 (+1.59), AET: 108.06 (-1.58), GOOG: 710.89 (-1.53), GPOR: 25.60 (+0.33), HOT: 70.55 (+0.48), HLT: 21.89 (+0.30), LYB: 82.00 (+2.10), COG: 21.47 (-0.70), WCG: 93.24 (-0.36), MA: 90.05 (+0.31), MNK: 62.15 (-1.44), WUBA: 55.70 (+1.45), WLL: 7.09 (+0.78), VRTX: 88.36 (-1.09), MCK: 162.77 (+0.07), ETN: 57.95 (+0.12), SEE: 45.68 (-0.84), AKRX: 25.08 (-0.80), PFE: 29.71 (-0.18), HAL: 34.88 (+0.71), LNG: 38.04 (+0.99), ETE: 8.33 (+0.43), TXT: 33.00 (-0.64), ALL: 65.38 (+0.07), PCLN: 1,297.71 (-5.33), QUNR: 36.95 (+0.73), WBA: 79.45 (-0.47), PXD: 128.80 (+0.53), MCD: 117.18 (+0.49), TEVA: 55.62 (+0.02), DOV: 63.20 (+0.75), AIG: 52.30 (+0.03), XRAY: 60.16 (-0.46), FDC: 13.59 (+0.80), CCI: 87.25 (-0.64), BIIB: 263.94 (-4.70), VRX: 61.31 (-3.58), CPN: 14.14 (+0.26), C: 42.83 (unch), ILMN: 156.14 (-1.31), CB: 117.18 (-0.66), MMC: 58.01 (+0.26), HUM: 183.25 (+0.03), AGN: 288.67 (-0.95), ANTM: 132.35 (-0.62), ECA: 5.47 (+0.54), PRQR: 4.54 (+0.14), EBAY: 24.41 (+0.47), SHPG: 160.39 (+0.20), CMG: 529.00 (+4.71), GOOGL: 730.22 (-1.37), CTRP: 40.02 (+0.78), SWN: 7.83 (+0.49), BK: 38.09 (+0.40), APD: 134.79 (-0.09), BHI: 46.20 (-0.35), APC: 45.26 (+2.28), AMZN: 575.14 (-2.35), ENDP: 42.44 (-0.73), MAR: 68.98 (+0.30), NFLX: 101.58 (+3.65), DVA: 70.51 (+0.43), KITE: 54.44 (+2.70), MHK: 186.82 (-0.07), TDG: 222.68 (+3.05), LH: 112.17 (+0.25), CP: 125.26 (+3.28), AFL: 61.03 (+0.05), AVGO: 146.06 (+8.73), BABA: 72.22 (+1.20)
Tracking John Paulson's Paulson & Company Portfolio - Q4 2015 Update
John Vincent - at Seeking Alpha - Sat Feb 20, 1:39PM CST
SGYP: 3.47 (-0.01), PRGO: 126.61 (+0.19), CAM: 67.79 (-0.03), CHTR: 184.78 (+1.11), INTC: 30.63 (+0.05), PCP: 234.95 (+0.10), SLB: 74.83 (-0.02), CYBX: 69.95 (+0.86), HOT: 70.55 (+0.48), STAY: 14.82 (-0.27), CSC: 30.51 (-0.26), TMUS: 38.48 (-0.49), MNK: 62.15 (-1.44), WLL: 7.09 (+0.78), AKRX: 25.08 (-0.80), NCQ: 0.46 (+0.05), AU: 12.92 (-0.36), MYL: 44.78 (-0.95), MGM: 19.81 (-0.52), WWAV: 41.15 (+0.60), NG: 5.02 (-0.01), LIVN: 57.94 (+0.19), TEVA: 55.62 (+0.02), AIG: 52.30 (+0.03), BRK.B: 137.97 (+1.13), BRK.A: 207,945.00 (+1,945.00), OAS: 6.91 (+0.22), VRX: 61.31 (-3.58), VNDA: 7.92 (-0.21), ALTR: 53.96 (+0.03), CZR: 8.80 (-0.15), CVC: 33.28 (+0.03), CIE: 3.41 (+0.21), AGN: 288.67 (-0.95), CACQ: 5.75 (-0.15), SHPG: 160.39 (+0.20), TWC: 195.33 (+0.90), BXLT: 39.47 (+0.17), ENDP: 42.44 (-0.73), OUT: 21.56 (+0.06), BAC: 13.54 (+0.04), MAR: 68.98 (+0.30), GRFS: 15.22 (-0.27), HCA: 73.00 (+0.07), POST: 71.75 (-0.45), RDN: 11.94 (+0.16), LRCX: 74.33 (-0.54), BAX: 39.46 (+0.13), GLD: 120.54 (-0.19), RLGY: 34.27 (+0.38), CIT: 33.17 (+1.11), HMHC: 19.96 (+0.19), MTG: 7.55 (-0.02), CSRA: 25.82 (-0.30)
Akorn Has Returned 20.2% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Feb 05, 10:52AM CST
SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on January 12th, 2016 at $31.33. In approximately 3 weeks, Akorn has returned 20.20% as of today's recent price of $25.00.
AKRX: 25.08 (-0.80)
Shares of AKRX Down 14.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 28, 5:41PM CST
SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on January 12th, 2016 at $31.33. In approximately 2 weeks, Akorn has returned 14.55% as of today's recent price of $26.77.
AKRX: 25.08 (-0.80)
Akorn Announces Conclusion of Audit Committee Independent Investigation
GlobeNewswire - Wed Jan 27, 3:34PM CST
Akorn, Inc. (Nasdaq:AKRX) today announced that the Audit Committee of Akorn's Board of Directors concluded its independent investigation into Akorn's accounting and other matters.
AKRX: 25.08 (-0.80)
Akorn Appoints Greg Lawless as Chief Human Resources Officer
GlobeNewswire - Thu Jan 21, 6:06AM CST
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P. Lawless joined Akorn as Chief Human Resources Officer on January 18, 2016.
AKRX: 25.08 (-0.80)
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
GlobeNewswire - Tue Jan 19, 6:00AM CST
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched Buprenorphine and Naloxone Sublingual Tablets CIII in 2mg/0.5mg and 8mg/2mg strengths. This launch follows an October 15, 2015 Food and Drug Administration (FDA) approval for the product. Additionally, Akorn recently launched Tobramycin Injection, USP 40 mg/mL in 2 mL and 30 mL multi-dose vials. This launch follows a September 2014 approval for the product.
AKRX: 25.08 (-0.80)
Why Akorn, Inc. Stock Dropped 10% Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Jan 15, 2:30PM CST
Image source: Akorn. W hat: Following a business update related to its ongoing investigation of material weakness in its financial accounting, shares of Akorn fell 10% earlier today. So what: After revealing material weaknesses early...
AKRX: 25.08 (-0.80)
Akorn Provides Material Updates
GlobeNewswire - Thu Jan 14, 4:25PM CST
- BDO USA, LLP Engaged as Independent Registered Public Accounting Firm -
AKRX: 25.08 (-0.80)
Look for Shares of Akorn to Potentially Rebound after Yesterday's 11.64% Sell Off
Comtex SmarTrend(R) - Tue Jan 12, 4:21PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $28.41 to a high of $34.25. Yesterday, the shares fell 11.6%, which took the trading range below the 3-day low of $32.57 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 25.08 (-0.80)
Shares of AKRX Up 19.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Jan 11, 6:37PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 19.30% as of today's recent price of $33.75.
AKRX: 25.08 (-0.80)
Top-Notch Funds Buying Constellation, Northrop Grumman
at Investor's Business Daily - Fri Jan 08, 4:56PM CST
The Santa Claus rally fizzled out in the later part of December amid the oil rout and the Fed's long-awaited rate bump. The S&P 500 rose 6.8% for the fourth quarter, but edged down 1.6% in December. The Nasdaq gained 8.4% in the last quarter of the...
GE: 30.46 (+0.24), NOC: 191.07 (-1.05), AKRX: 25.08 (-0.80), PSA: 249.95 (-3.26), STZ: 143.90 (-0.55), EXR: 83.98 (-0.85), ELS: 70.85 (-1.22), ICLR: 71.95 (-0.42), NVDA: 32.55 (-0.10), LUV: 41.50 (-0.53), AGN: 288.67 (-0.95), CNC: 58.75 (-1.57), ISRG: 570.65 (-3.39), CBPO: 110.00 (-0.70), AYI: 220.30 (-1.83), ULTA: 168.97 (-0.41)
Shares of AKRX Up 34.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Jan 04, 4:48PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 34.68% as of today's recent price of $38.10.
AKRX: 25.08 (-0.80)
Akorn Has Returned 31.6% Since SmarTrend Recommendation (AKRX)
Comtex SmarTrend(R) - Mon Dec 28, 9:20AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 2 months, Akorn has returned 31.64% as of today's recent price of $37.24.
AKRX: 25.08 (-0.80)
Akorn Set to Possibly Pullback After Yesterday's Rally of 1.55%
Comtex SmarTrend(R) - Tue Dec 22, 4:52PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.40 to a high of $37.14. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $36.83 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 25.08 (-0.80)
27.4% Return Seen to Date on SmarTrend Akorn Call (AKRX)
Comtex SmarTrend(R) - Fri Dec 18, 7:58PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 1 month, Akorn has returned 27.36% as of today's recent price of $36.03.
AKRX: 25.08 (-0.80)
Akorn Shares Up 22.2% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Fri Dec 11, 6:16PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 1 month, Akorn has returned 22.20% as of today's recent price of $34.57.
AKRX: 25.08 (-0.80)
Akorn Up 23.5% Since SmarTrend Uptrend Call (AKRX)
Comtex SmarTrend(R) - Fri Dec 04, 1:42PM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 4 weeks, Akorn has returned 23.52% as of today's recent price of $34.95.
AKRX: 25.08 (-0.80)
Upgrade Alert for Akorn (AKRX)
Comtex SmarTrend(R) - Wed Dec 02, 7:03AM CST
Akorn (NASDAQ:AKRX) was upgraded from Neutral to Buy at Nomura today. The stock closed yesterday at $34.55 on volume of 1.2 million shares, below average daily volume of 1.6 million. In the past 52 weeks, Akorn share prices have been bracketed by a low of $19.08 and a high of $57.10 and closed yesterday at $34.55, 81% above that low price. The 200-day and 50-day moving averages have moved 0.5% lower and 1.02% lower over the past week, respectively.
AKRX: 25.08 (-0.80)
Uptrend Call Working As Akorn Stock Rises 18.6% (AKRX)
Comtex SmarTrend(R) - Fri Nov 27, 11:14AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on November 5th, 2015 at $28.29. In approximately 3 weeks, Akorn has returned 18.59% as of today's recent price of $33.55.
AKRX: 25.08 (-0.80)
